SUSQUEHANNA INTERNATIONAL GROUP, LLP - AGEX THERAPEUTICS INC ownership

AGEX THERAPEUTICS INC's ticker is AGE and the CUSIP is 00848H108. A total of 34 filers reported holding AGEX THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
SUSQUEHANNA INTERNATIONAL GROUP, LLP ownership history of AGEX THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$16,508
-57.6%
24,276
-44.4%
0.00%
Q2 2023$38,974
+92.1%
43,634
+42.6%
0.00%
Q1 2023$20,285
-29.8%
30,596
-41.6%
0.00%
Q4 2022$28,909
+122.4%
52,381
+254.2%
0.00%
Q1 2022$13,000
-77.6%
14,790
-72.1%
0.00%
Q4 2021$58,000
+176.2%
53,044
+400.1%
0.00%
Q3 2019$21,000
-91.1%
10,606
-83.5%
0.00%
Q2 2019$235,00064,1250.00%
Other shareholders
AGEX THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
BROADWOOD CAPITAL INC 2,997,156$4,646,0000.21%
Strategic Wealth Investment Group, LLC 65,187$101,0000.04%
Defender Capital, LLC. 34,897$54,0000.02%
Beirne Wealth Consulting Services, LLC 18,000$28,0000.02%
Prescott General Partners LLC 185,185$287,0000.01%
Summit X, LLC 20,500$32,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 244,770$379,0000.01%
Piscataqua Savings Bank 1,000$2,0000.00%
Sigma Planning Corp 51,700$80,0000.00%
Riggs Asset Managment Co. Inc. 1,160$2,0000.00%
View complete list of AGEX THERAPEUTICS INC shareholders